TNF-alpha-mediates neuroprotection against glutamate-induced excitotoxicity via NF-kappaB-dependent up-regulation of K2.2 channels

J Neurochem. 2008 Nov;107(4):1158-67. doi: 10.1111/j.1471-4159.2008.05701.x. Epub 2008 Sep 24.

Abstract

Previous studies have shown that tumor necrosis factor-alpha (TNF-alpha) induces neuroprotection against excitotoxic damage in primary cortical neurons via sustained nuclear factor-kappa B (NF-kappaB) activation. The transcription factor NF-kappaB can regulate the expression of small conductance calcium-activated potassium (K(Ca)) channels. These channels reduce neuronal excitability and as such may yield neuroprotection against neuronal overstimulation. In the present study we investigated whether TNF-alpha-mediated neuroprotective signaling is inducing changes in the expression of small conductance K(Ca) channels. Interestingly, the expression of K(Ca)2.2 channel was up-regulated by TNF-alpha treatment in a time-dependent manner whereas the expression of K(Ca)2.1 and K(Ca)2.3 channels was not altered. The increase in K(Ca)2.2 channel expression after TNF-alpha treatment was shown to be dependent on TNF-R2 and NF-kappaB activation. Furthermore, activation of small conductance K(Ca) channels by 6,7-dichloro-1H-indole-2,3-dione 3-oxime or cyclohexyl-[2-(3,5-dimethyl-pyrazol-1-yl)-6-methyl-pyrimidin-4-yl]-amine-induced neuroprotection against a glutamate challenge. Treatment with the small conductance K(Ca) channel blocker apamin or K(Ca)2.2 channel siRNA reverted the neuroprotective effect elicited by TNF-alpha. We conclude that treatment of primary cortical neurons with TNF-alpha leads to increased K(Ca)2.2 channel expression which renders neurons more resistant to excitotoxic cell death.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Survival / drug effects
  • Cell Survival / genetics
  • Cells, Cultured
  • Cerebral Cortex / cytology
  • Embryo, Mammalian
  • Enzyme Inhibitors / pharmacology
  • Glutamic Acid / toxicity*
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • NF-kappa B / metabolism*
  • Neurons / drug effects
  • Neuroprotective Agents / metabolism
  • Neuroprotective Agents / pharmacology
  • Neurotoxicity Syndromes / etiology*
  • Neurotoxicity Syndromes / prevention & control*
  • Nitriles / pharmacology
  • RNA, Small Interfering / pharmacology
  • Receptors, Tumor Necrosis Factor, Type I / deficiency
  • Receptors, Tumor Necrosis Factor, Type II / deficiency
  • Small-Conductance Calcium-Activated Potassium Channels / genetics
  • Small-Conductance Calcium-Activated Potassium Channels / metabolism*
  • Subcellular Fractions / drug effects
  • Subcellular Fractions / metabolism
  • Sulfones / pharmacology
  • Time Factors
  • Tumor Necrosis Factor-alpha / metabolism*
  • Tumor Necrosis Factor-alpha / pharmacology
  • Up-Regulation / drug effects
  • Up-Regulation / genetics
  • Up-Regulation / physiology*

Substances

  • 3-(4-methylphenylsulfonyl)-2-propenenitrile
  • Enzyme Inhibitors
  • NF-kappa B
  • Neuroprotective Agents
  • Nitriles
  • RNA, Small Interfering
  • Receptors, Tumor Necrosis Factor, Type I
  • Receptors, Tumor Necrosis Factor, Type II
  • Small-Conductance Calcium-Activated Potassium Channels
  • Sulfones
  • Tumor Necrosis Factor-alpha
  • Glutamic Acid